Exercise and the Menstrual Cycle in Type 1 Diabetes
ConditionType 1 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorUniversity of Alberta
About this trial
Female participants with type 1 diabetes using oral contraceptives will be asked to wear a continuous glucose monitor for at least three days on two separate occasions (once during the last week of active pills and once during the no pill/placebo pill phase of the menstrual cycle). An exercise session (45 minutes of aerobic exercise at 60% VO2peak on a cycle ergometer) will take place at 5 pm on the second day of glucose monitoring.
Eligibility criteria
Qualifiers
type 1 diabetes diagnosed for at least 1 year
regular menses
using monophasic oral contraceptives
residing in Edmonton, Alberta and able to visit the lab at the University of Alberta
Disqualifiers
HbA1c > 9.9%
frequent and unpredictable hypoglycemia
change in insulin management strategy within two months of the study
use of an automated insulin delivery system
Trial design
Treatments tested in this trial
- Luteal Phase Aerobic Exercise
- Follicular Phase Aerobic Exercise
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Alberta
Lead sponsor
Women and Children's Health Research Institute, Canada
Collaborator
Source ClinicalTrials.gov